At Mercodia, we are the premier bioanalytical CRO specialized in cardiometabolic diseases.
Our skilled team and dedicated experience offer exceptional insight into the specific biomarkers and challenges unique to diabetes, obesity, and related cardiorenal-metabolic conditions.
We’ve led over 200 cardiometabolic bioanalytical studies and analyzed hundreds of thousands of samples. This real-world expertise allows us to troubleshoot the most complex assays and matrices and design a successful bioanalytical strategy for all stages of preclinical and clinical development.
Don’t let bad data stall your progress. Go beyond generic bioanalysis.
Selecting the right bioanalytical CRO partner is a critical decision that can make or break your program
. . .
Mercodia is designed to deliver on every one of them
Experience personalized service and communication clarity with a dedicated project manager from initial discussion to project delivery. You won’t have to chase us for updates.
We prioritize flexibility, adapting our approach to your unique needs, understanding that drug development isn’t one-size-fits-all.
Our drug–developer mindset means we think like you, anticipating challenges and opportunities. We partner early and iterate quickly, actively working to avoid any delays.
Our science-first approach guarantees results that make sense, providing true understanding for your research. We don’t just generate numbers; we contribute scientific understanding to advance your research and development.
Data is rigorously built for pivotal decisions across PK, PD, biomarkers, and ADA, ensuring you can move forward with certainty.
We deliver data integrity designed to meet rigorous standards, avoiding costly stalls and ensuring smooth progression. Our proven track record with audits from regulatory authorities and sponsors speaks volumes about our high GLP/GCP standards and robust data integrity systems.
Our scientists are intimately familiar with the intricacies of immunoassay development, ensuring optimal performance for your samples.
We apply rigorous product development principles to our services, ensuring assays are robust, reproducible, and reliable.
Our product expertise enhances our service delivery, providing a holistic approach to your bioanalytical needs.
Leverage our unique portfolio of gold-standard cardiometabolic biomarkers, developed with decades of in-house R&D.
Experience personalized service and communication clarity with a dedicated project manager from initial discussion to project delivery. You won’t have to chase us for updates.
We prioritize flexibility, adapting our approach to your unique needs, understanding that drug development isn’t one-size-fits-all.
Our drug–developer mindset means we think like you, anticipating challenges and opportunities. We partner early and iterate quickly, actively working to avoid any delays.
Our science-first approach guarantees results that make sense, providing true understanding for your research. We don’t just generate numbers; we contribute scientific understanding to advance your research and development.
Data is rigorously built for pivotal decisions across PK, PD, biomarkers, and ADA, ensuring you can move forward with certainty.
We deliver data integrity designed to meet rigorous standards, avoiding costly stalls and ensuring smooth progression. Our proven track record with audits from regulatory authorities and sponsors speaks volumes about our high GLP/GCP standards and robust data integrity systems.
Our scientists are intimately familiar with the intricacies of immunoassay development, ensuring optimal performance for your samples.
We apply rigorous product development principles to our services, ensuring assays are robust, reproducible, and reliable.
Our product expertise enhances our service delivery, providing a holistic approach to your bioanalytical needs.
Leverage our unique portfolio of gold-standard cardiometabolic biomarkers, developed with decades of in-house R&D.
Countries
Years´experience
Biomarkers
Cardiometabolic studies
We seamlessly integrate with your team, working as true collaborators dedicated to your program’s success
. . .
Chief Scientific and Medical Officer, Annexin Pharmaceuticals AB
Here at Annexin Pharmaceuticals we have truly enjoyed working together with Mercodia. The very experienced bioanalytical scientists at Mercodia have become an integral part of the Annexin team. Together, we shared scientific curiosity and critical thinking while never compromising on the quality of data. I would never think twice about working with Mercodia again.
Chief Development Officer, Glyscend Therapeutics
Mercodia is a recognized leader in the industry for reliable metabolic biomarker assays. Working with them during our clinical trials not only added validity to our studies but also gave us the confidence that the data we collected would truly give us insight into the pharmacology of our drug. Mercodia was easy to work with, timely, and engaged in thoughtful discussions, making them a great partner from start to finish.
Operations Manager at Cellular Longevity
The Mercodia team worked diligently in our project and delivered reliable data when we needed it. It was easy to collaborate with such an expert team of scientists and we look forward to more exciting projects together.
Are you ready to take your bioanalysis strategy to the next level?
Let’s discuss how we can work together to reach your milestones.
info-global@mercodia.com
+46 18 57 00 70
Customer Success Manager & Area Sales Manager Nordics
robert.almstedt@mercodia.com (+46) 72 292 15 08